Skip to content
PeptideTech
Cart

Home / Research library / RAD-140

Other compounds

RAD-140: molecular data, studies & sources

RAD-140 is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular record not yet resolved

A sufficiently specific molecular record was not resolved for this name. Formula, molecular weight and structure are withheld until the exact sequence, salt or preparation can be verified.

MF: not assigned · MW: not assigned · Structure: not assigned

Registered clinical trials

Studies registered on ClinicalTrials.gov that list RAD-140 as an intervention. Studies that only measure the molecule as a biomarker are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.

1 registered study matched.

StudyPhase · statusConditionsSponsor · size
A Phase 1, First-in-Human, Multi-Part Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast CancerNCT03088527 · start 2017-10-23 · primary completion 2020-08-28Phase 1CompletedHormone Receptor Positive Malignant Neoplasm of BreastStemline Therapeutics, Inc.20 participants

Registry check 2026-10-01 · Run this search on ClinicalTrials.gov

Human and clinical studies

Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.

No matching human study was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.

    Preclinical research, reviews & other publications

    Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

    1. Case report

      Drug-Induced Liver Injury Associated With Alpha Bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033).

      Barbara M, Dhingra S, Mindikoglu AL et al. · ACG case reports journal · 2020

      PMID 33062783 · DOI: 10.14309/crj.0000000000000409

    2. Case report

      Myopericarditis Following Use of Selective Androgen Receptor Modifier "RAD-140".

      Schwartzman KH, Kohli U, Chaudhuri NR et al. · JACC. Case reports · 2024

      PMID 39157568 · DOI: 10.1016/j.jaccas.2024.102423

    3. Preclinical / laboratory research

      Label-free proteomics for discovering biomarker candidates of RAD140 administration to castrated horses.

      Cheung HW, Wong KS, To NS et al. · Drug testing and analysis · 2021

      PMID 33277807 · DOI: 10.1002/dta.2988

    4. Research publication · design requires review

      Unregulated gains: a case of RAD-140-induced liver injury.

      Dao D, King B, Dao H et al. · Proceedings (Baylor University. Medical Center) · 2026

      PMID 42417499 · DOI: 10.1080/08998280.2026.2691619

    5. Research publication · design requires review

      Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes.

      Wagener F, Euler L, Görgens C et al. · Metabolites · 2022

      PMID 35888790 · DOI: 10.3390/metabo12070666

    6. Preclinical / laboratory research

      Selective androgen receptor modulator RAD140 is neuroprotective in cultured neurons and kainate-lesioned male rats.

      Jayaraman A, Christensen A, Moser VA et al. · Endocrinology · 2014

      PMID 24428527 · DOI: 10.1210/en.2013-1725

    7. Case report

      Selective androgen receptor modulator abuse-induced heart failure: catastrophic effects of RAD-140 (Testolone).

      Skorupski WJ, Marko A, Janus M et al. · Polish archives of internal medicine · 2024

      PMID 38864168 · DOI: 10.20452/pamw.16770

    8. Case report

      Acute Myocarditis From the Use of Selective Androgen Receptor Modulator (SARM) RAD-140 (Testolone).

      Padappayil RP, Chandini Arjun A, Vivar Acosta J et al. · Cureus · 2022

      PMID 35233331 · DOI: 10.7759/cureus.21663

    RAD-140 supplier sources

    Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

    No priced supplier offers are currently available in this catalog view. The research record remains available independently of stock.

    Reference sources & further reading

      The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

      Search for additional research

      These links run searches; their results have not been individually reviewed and can include unrelated compounds.

      Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

      Related research profiles

      Other compounds

      Ostarine

      C19H14F3N3O3

      389.33 g/mol · ChEMBL CHEMBL1738889

      8 selected publications · 0 human study records · 17 registered trials

      Small molecule · highest stage: Phase 3

      Structure, studies & sources →